(Q40248309)

English

The predominant CD44 splice variant in prostate cancer binds fibronectin, and calcitonin stimulates its expression.

scientific article published on July 2006

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16886606

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16886606%20AND%20SRC:MED&resulttype=core&format=json

retrieved

28 December 2019

title

The predominant CD44 splice variant in prostate cancer binds fibronectin, and calcitonin stimulates its expression (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16886606

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16886606%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

1

Kenneth A Iczkowski

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16886606

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16886606%20AND%20SRC:MED&resulttype=core&format=json

retrieved

28 December 2019

author name string

A Levi Omara-Opyene

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16886606

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16886606%20AND%20SRC:MED&resulttype=core&format=json

retrieved

28 December 2019

Girish V Shah

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16886606

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16886606%20AND%20SRC:MED&resulttype=core&format=json

retrieved

28 December 2019

language of work or name

English

0 references

publication date

1 July 2006

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16886606

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16886606%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

1 reference

Europe PubMed Central

PubMed publication ID

16886606

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16886606%20AND%20SRC:MED&resulttype=core&format=json

retrieved

28 December 2019

volume

26

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16886606

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16886606%20AND%20SRC:MED&resulttype=core&format=json

retrieved

28 December 2019

issue

4B

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16886606

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16886606%20AND%20SRC:MED&resulttype=core&format=json

retrieved

28 December 2019

page(s)

2863-2872

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16886606

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16886606%20AND%20SRC:MED&resulttype=core&format=json

retrieved

28 December 2019

Identifiers

PubMed publication ID

16886606

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16886606

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16886606%20AND%20SRC:MED&resulttype=core&format=json

(Q40248309)

The predominant CD44 splice variant in prostate cancer binds fibronectin, and calcitonin stimulates its expression.

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)